Therefore, it is important to accurately evaluate tumor pathology, including cell morphology and immunohistochemistry (accessing positiveness for KIT and DOG1), and the molecular profile [3] in order to improve the prediction of the biological behavior of the tumor and define the prognosis, as well as treatment response. This evidence concerns the gene ANO1 and neoplasm.